Astellas Pharma Inc.

Japon


Commandez votre montre hebdomadaire Astellas Pharma Inc.
Quantité totale PI 1 053
Quantité totale incluant filiales 1 423 (+ 373 pour les filiales)
Rang # Quantité totale PI 1 284
Note d'activité PI 3,4/5.0    502
Rang # Activité PI 1 398
Activité incl filiales 3,2/5.0    704
Symbole boursier
ISIN JP3942400007
Capitalisation 3705887172787.5  (JPY)
Industrie Drug Manufacturers—General
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

256 59
81 50
456 97
54
 
Dernier brevet 2025 - Quinazoline compound for inducin...
Premier brevet 1983 - 7-substituted-3-vinyl-3-cephem c...
Dernière marque 2025 - YOU IN UROLOGY
Première marque 1979 - JOSACINE

Filiales

13 subsidiaries with IP (185 patents, 188 trademarks)

7 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Providing medical information.
P/S Custom manufacture of pharmaceuticals Testing, inspection or research of pharmaceuticals, cosmeti...
P/S Education services, namely, providing classes in the field of healthcare Medical research service...
P/S Provide medical information
P/S Providing medical information
Invention Quinazoline compound for inducing degradation of g12d mutant kras protein. [Problem] To provide ...
P/S Provide medical information
P/S Computer application software for use with web-based platforms and mobile devices in the nature o...
Invention Antibody-drug complex containing toll-like receptor 7/8 dual agonist compound. A compound of for...
Invention Thrombin-carrying hemostatic sheet. Provided is a thrombin-carrying hemostatic sheet that is sui...
Invention Antibody-drug conjugate containing heterocyclic compound having activity of inducing decompositio...
Invention Heterocyclic compound for inducing degradation of kras protein. Provided is a compound useful as ...
P/S Downloadable computer application software for use with web-based platforms and mobile devices in...
Invention Anti-cldn4/anti-cd137 bispecific antibody. An object of the present invention is to provide an a...
2024 Invention Pharmaceutical composition for treating spinal cord injury and method for producing non-human pri...
Invention Carbamoyl lipid having cyclic group in side chain, lipid nanoparticles thereof, and pharmaceutica...
Invention Combination therapy involving bispecific binding agents binding to cldn18.2 and cd3 and anti-vegf...
Invention Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer p...
Invention Azacycloalkyl carbonyl cyclic amine compound. Provided is an azacycloalkylcarbonyl cyclic amine ...
Invention Formulations of enzalutamide. This disclosure provides formulations of enzalutamide and their us...
P/S Downloadable computer application software for use with web-based tablet computers, personal digi...
P/S Pharmaceutical preparations for intraoperative ureter and lymph node visualization for use during...
Invention Training assistance device, training assistance program, training assistance system, and non-tran...
Invention Antibody-drug complex containing toll-like receptor 7/8 dual agonist compound. An antibody-drug c...
Invention Anti-mertk agonist antibody, anti-mertk bispecific antibody, and use thereof. The present inventi...
Invention Shorts. A pair of shorts comprising: a shorts body (outer fabric, inner fabric); a band-like memb...
Invention Method for producing compound encoded by oligonucleotide, and application thereof. The purpose of...
Invention Selective production of single axially chiral compound. As one embodiment, the present invention ...
Invention Recombinant adeno-associated virus comprising truncated cmv promoter sequence and/or truncated po...
Invention Fc region variant. According to one embodiment, provided is a sialylated Fc region variant compri...
Invention Idez variant. According to one embodiment of the present invention, provided is an IdeZ variant h...
Invention Modified bacteriophage. The present invention provides a bacteriophage having bacteriolytic activ...
Invention Pharmaceutical composition containing tagged site-antihuman antibody fab fragment complex. Provi...
Invention Combination therapy involving antibodies against claudin 18.2 for treatment of cancer. The prese...
Invention Pharmaceutical composition comprising a pan-kras degrader. There is provided herein a compound of...
Invention Pharmaceutical composition comprising a quinazoline compound. There is provided herein compounds ...
Invention Cell penetrating peptide. An object of the present invention is to provide a cell penetrating pe...
Invention Method for producing type 2 innate lymphocytes. The present invention addresses the problem of es...
Invention Ppar-delta inhibitors for preventing post-operative atrial fibrillation. The present invention is...
Invention Pharmaceutical composition for modified release. A pharmaceutical composition for modified releas...
Invention Terminal apparatus, game execution method, program, and server. This terminal apparatus is for ex...
P/S incubation services, namely, rental of office space to freelancers and start-ups Rental of labora...
P/S Provision of incubation services, namely, arranging of business resources and/or finance for busi...
2023 Invention Combination therapy involving bispecific binding agents binding to cldn18.2 and cd3 and agents st...
P/S Pharmaceutical product for the treatment of cancer.
P/S Pharmaceutical product for the treatment of cancer.
P/S Pharmaceutical product for the treatment of cancer
P/S provision of incubation services, namely, arranging of business resources and/or finance for busi...
P/S Incubation services, namely, rental of office space to freelancers and start-ups Rental of labora...
P/S Business administration of health reimbursement arrangements; providing business information rega...
Invention Method for selective production of single axially chiral compound. Problem: When a compound havin...
Invention Heterocyclic compound acting on g12d mutant kras protein. [Problem] To provide a compound useful...
Invention Methods for treating patients with locally advanced and/or metastatic solid tumors using a dgk ze...
Invention Pharmaceutical composition containing anti-integrin alpha11 antibody for treatment or prevention ...
Invention Anti-taa/anti-cd3 multispecific antibody. An object of the present invention is to provide an an...
P/S Pharmaceutical products for the treatment of cancer.
P/S Pharmaceutical preparations for the treatment of cancer.
P/S Pharmaceutical preparations for the treatment of cancer
Invention Heterocyclic compound for inducing degradation of g12d mutant kras protein. To provide a compoun...
P/S Downloadable medical software for processing and displaying images on ultrasound medical imaging ...
P/S Pharmaceutical preparations. Software for medical purposes; computer programs; telecommunication ...
P/S Pharmaceutical preparations for the treatment of type2 diabetes mellitus, metabolic syndrome, bla...
Invention Aryl alkynamide derivatives. A compound which is useful as a STING inhibitor is provided. The pr...
2022 Invention Substituted quinoline derivative. The present inventors have studied and found that the substitu...
Invention Pharmaceutical composition comprising a quinazoline compound. The present invention has an objec...
Invention Indocyanine compound-containing solid pharmaceutical composition. Provided is a stable solid pha...
P/S Pharmaceutical preparation for the treatment of cancer and for gastrointestinal disorders and dis...
Invention A pharmaceutical composition for imaging. Intraoperative ureter identification helps reduce the ...
Invention Vascular endothelial growth factor (vegf)-highly expressing pericyte-like cell. An object of the...
Invention Method for producing vascular endothelial growth factor (vegf)- highly expressing pericyte-like c...
Invention Methods of use of ppar agonist compounds and pharmaceutical compositions thereof. The present di...